Nedap N.V. (AMS:NEDAP)

Ligand Pharmaceuticals Revenue

Nedap had revenue of 134.88M EUR in the half year ending June 30, 2025, with 0.35% growth. This brings the company's revenue in the last twelve months to 262.42M, up 4.11% year-over-year. In the year 2024, Nedap had annual revenue of 251.61M, down -4.12%.

• Revenue (ttm): 262.42M
• Revenue Growth: +4.11%
• P/S Ratio: 2.16
• Revenue / Employee: 257.28K
• Employees: 938
• Market Cap: 565.95M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	251.61M	-10.82M	-4.12%
Dec 31, 2023	262.43M	32.95M	14.36%
Dec 31, 2022	229.48M	22.47M	10.85%
Dec 31, 2021	207.01M	17.10M	9.00%
Dec 31, 2020	189.92M	-1.63M	-0.85%